Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Samantha A, Dunn"'
Autor:
Oluwadamilola T. Oladeru, Samantha A. Dunn, Jian Li, Charlotte E. Coles, Chikako Yamauchi, Jee Suk Chang, Skye Hung-Chun Cheng, Orit Kaidar-Person, Icro Meattini, Duvern Ramiah, Anna Kirby, Tarek Hijal, Gustavo Nader Marta, Philip Poortmans, Josep Isern-Verdum, Yvonne Zissiadis, Birgitte Vrou Offersen, Tamer Refaat, Khaled Elsayad, Hussam Hijazi, Natalia Dengina, Yazid Belkacemi, Feng Deng Luo, Shun Lu, Colleen Griffin, Maya Collins, Phoebe Ryan, Dalia Larios, Laura E. Warren, Rinaa S. Punglia, Julia S. Wong, Daphna Y. Spiegel, Reshma Jagsi, Alphonse Taghian, Jennifer R. Bellon, Alice Y. Ho
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEThe COVID-19 pandemic has profoundly affected cancer care worldwide, including radiation therapy (RT) for breast cancer (BC), because of risk-based resource allocation. We report the evolution of international breast RT practices during the be
Externí odkaz:
https://doaj.org/article/2bb67824887640d0ba3f90a1250de6e7
Publikováno v:
Seminars in Radiation Oncology. 32:291-297
Immune checkpoint inhibitors (ICI) can have significant anticancer activity, and are approved for many different cancer types, including breast cancer. In breast cancer, programmed cell death 1 (PD-1) inhibitors in combination with chemotherapy have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f49e2c7d152f37ef0cdbc0eccc0fef4
https://doi.org/10.1016/j.semradonc.2022.01.001
https://doi.org/10.1016/j.semradonc.2022.01.001
Publikováno v:
Breast Cancer Research and Treatment. 191:229-241
Purpose Immune checkpoint inhibition (ICI) has demonstrated clinically significant efficacy when combined with chemotherapy in triple negative breast cancer (TNBC). Although many patients derived benefit, others do not respond to immunotherapy, there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77a193315cba3cad20ca496267bb8fc8
https://doi.org/10.1007/s10549-021-06408-z
https://doi.org/10.1007/s10549-021-06408-z
Autor:
Makenzie R. Norris, John Bilbily, Léa J. Becker, Gustavo Borges, Yu-Hsuan Chang, Samantha S. Dunn, Manish K. Madasu, Ream Al-Hasani, Meaghan C. Creed, Jordan G. McCall
Neuropathic pain causes both sensory and emotional maladaptation. Preclinical animal studies of neuropathic pain-induced negative affect could result in novel insights into the mechanisms of chronic pain. Modeling pain-induced negative affect, howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea4cf32b7c3d0afeed34f18cc4c08773
https://doi.org/10.1101/2022.11.10.515959
https://doi.org/10.1101/2022.11.10.515959
Autor:
Faina Nakhlis, Leah Portnow, Eva Gombos, Ayse Ece Cali Daylan, Jose Pablo Leone, Olga Kantor, Edward T. Richardson, Alice Ho, Samantha Armstrong Dunn, Nisha Ohri
Publikováno v:
Current problems in surgery. 59(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e90b748d95663997ebb502691b8293b
https://pubmed.ncbi.nlm.nih.gov/36109127
https://pubmed.ncbi.nlm.nih.gov/36109127
Autor:
Samantha A. Dunn, Alice Y. Ho, Nicolas Depauw, Oluwadamilola T. Oladeru, Liam T. Vanbenthuysen
Publikováno v:
Current Breast Cancer Reports. 12:285-295
In recent years, there have been a number of small, yet notable practice changes in the delivery of postmastectomy radiation therapy (PMRT) in breast cancer patients. Herein, we describe the role of PMRT and its evolving delivery with hypofractionate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e59a4cd4f33cf0daa98752922fdf58d
https://doi.org/10.1007/s12609-020-00385-w
https://doi.org/10.1007/s12609-020-00385-w
Publikováno v:
Practical Guides in Radiation Oncology ISBN: 9783030995898
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c900332eea8eb087c5d34ce653eb688d
https://doi.org/10.1007/978-3-030-99590-4_12
https://doi.org/10.1007/978-3-030-99590-4_12
Publikováno v:
The Journal of Pain. 23:24-25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1244f47a6ed832e1ec867d6b838cf2a7
https://doi.org/10.1016/j.jpain.2022.03.096
https://doi.org/10.1016/j.jpain.2022.03.096
Autor:
Heather L McArthur, Stephen Shiao, Scott Karlan, Reva Basho, Farin Amersi, Michele Burnison, Amin Mirhadi, Alice Chung, Cathie T Chung, Catherine Dang, Heather Richardson, Armando E Giuliano, Nimmi Kapoor, Brigid Larkin, Hector Godinez, Samantha A Dunn, Negin Habibi Khameneh, Simon Knott, Philomena McAndrew, Monica Mita, Dorothy J Park, Christina Abaya, Jonathan H Chen, Amy Ly, Veerle Bossuyt, Alice Ho
Publikováno v:
Cancer Research. 82:PD10-01
Background: Anti-PD(L)1 in addition to neoadjuvant chemotherapy (NAC) can achieve pathologic complete response (pCR) rates of up to 65% in patients with early stage triple negative breast cancer (TNBC). However, patients with non-pCR can have dismal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e60a6ca412c7fa40bf5c71606187e193
https://doi.org/10.1158/1538-7445.sabcs21-pd10-01
https://doi.org/10.1158/1538-7445.sabcs21-pd10-01
Autor:
Lizza Lebron-Zapata, Jessica Flynn, Samantha A. Dunn, Christopher A. Barker, Alice Y. Ho, Brittany Arnold, Alessandro D'Agnolo, Simon N. Powell, Cindy Kallman, Hannah Y Wen, Heather L. McArthur, Ayca Gucalp, Zishuo I. Hu, Zhigang Zhang
Publikováno v:
Cancer. 126:850-860
Background The current study was conducted to evaluate the efficacy and safety of pembrolizumab-mediated programmed cell death protein 1 inhibition plus radiotherapy (RT) in patients with metastatic triple-negative breast cancer who were unselected f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24d5c898e9ad0fa0f0c3930aa6e73600
https://doi.org/10.1002/cncr.32599
https://doi.org/10.1002/cncr.32599